Where next for the Dow after breaking above 30,000?
Fiona Cincotta November 25, 2020 6:19 AM
The Dow Jones climbed over 400 points in the previous session, crossing 30,000 for the first time ever amid upbeat vaccine news, optimism surrounding the economic recovery & US political clarity.
The Dow Jones climbed over 400 points in the previous session, crossing 30,000 for the first time ever amid upbeat vaccine news, optimism surrounding a strong economic recovery in the coming year and improving political clarity after Trump’s administration approved the start of the transition presidential period.
News that ex-Federal Reserve Chair Janet Yellen will be Treasury Secretary also gave the markets a boost given that she is seen as a market friendly candidate and one who will work closely with Jerome Powell. Markets are interpreting her appointment as a sign that Joe Biden could focus more on rebuilding the economy than rather than pursuing aggressive regulatory policy.
The rally from 20,000 (crossed January 2017) – 30,000 was helped by a big lift from tech with Apple, Microsoft and Salesforce surging over 230% across the same period. However, the latest runup the surge in the Dow is thanks in part to a catch up trade in value stocks. Across the pandemic, big tech was massively in favour with investors basically rising the wave of 5 mega tech stocks. Now the doors have opened to a much broader selection of stocks. Value stocks have been hugely in favour this month on vaccine developments and hopes surrounding the economic recovery.
When big milestones are reached this can provoke Fear of Missing Out (FOMO) making a deep selloff after the milestone less likely. That said given the rapid run up from the lows could mean it needs to consolidate. As a result, reaching 40,000 could take longer than the 20,000 – 30,000 run up. There’s also a good chance that the market will want to see some more stimulus before pushing too much higher.
Sectors to watch
Tech is expected to remain a favourite but could well be joined by other sectors and industries. More recently investors have been backing cyclical stocks such as industrials, materials and financials. These are sectors that will do well when the economy reopens and rebounds next year
Health related stocks such as Johnson & Johnson, United Health could also have plenty of upside. Healthcare stocks have underperformed for a good part of the year on fears that a progressive Democrat in the White House would change healthcare legislation. The group has advanced since Joe Biden won, but there could well be more steam left in this rally , especially if a Blue wave looks less likely.
Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.
Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.